The First Affiliated Hospital, Shantou University Medical College, Shantou 515041, China.
Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Cells. 2021 Jul 23;10(8):1872. doi: 10.3390/cells10081872.
Spinal cord injury (SCI) is a debilitating condition, often leading to severe motor, sensory, or autonomic nervous dysfunction. As the holy grail of regenerative medicine, promoting spinal cord tissue regeneration and functional recovery are the fundamental goals. Yet, effective regeneration of injured spinal cord tissues and promotion of functional recovery remain unmet clinical challenges, largely due to the complex pathophysiology of the condition. The transplantation of various cells, either alone or in combination with three-dimensional matrices, has been intensively investigated in preclinical SCI models and clinical trials, holding translational promise. More recently, a new paradigm shift has emerged from cell therapy towards extracellular vesicles as an exciting "cell-free" therapeutic modality. The current review recapitulates recent advances, challenges, and future perspectives of cell-based spinal cord tissue engineering and regeneration strategies.
脊髓损伤(SCI)是一种使人虚弱的疾病,常导致严重的运动、感觉或自主神经功能障碍。作为再生医学的圣杯,促进脊髓组织再生和功能恢复是根本目标。然而,有效再生损伤的脊髓组织和促进功能恢复仍然是未满足的临床挑战,这主要归因于该疾病的复杂病理生理学。在临床前 SCI 模型和临床试验中,各种细胞的单独或与三维基质结合的移植已被深入研究,具有转化前景。最近,细胞治疗向细胞外囊泡作为一种令人兴奋的“无细胞”治疗方式发生了新的范式转变。本综述总结了基于细胞的脊髓组织工程和再生策略的最新进展、挑战和未来展望。